The present study showed that DDR mutation was associated with a favorable median OS in CRC patients treated with ICI (Figure 2A), but no significant difference was identified in the prognosis of patients with or without DDR mutation with conventional treatment (Figures 3A, C). Here, DDR1 is linked to colorectal carcinoma.